Allegiant Travel CO (ALGT) earnings date, results and what the price requires
Nasdaq · SEC CIK 0001362468 · SEC filings checked Oct 17, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 4, 2026 | $822.5M | $-4.9M | $-0.21 | Filing |
| Mar 31, 2026 | Apr 30, 2026 | $671.8M | $42.5M | $2.30 | Filing |
| Dec 31, 2025 | Feb 4, 2026 | $595.5M | $31.9M | $1.82 | Filing |
| Sep 30, 2025 | Nov 4, 2025 | $494.1M | $-43.6M | $-2.41 | Filing |
| Jun 30, 2025 | Aug 4, 2025 | $617.9M | $-65.2M | $-3.62 | Filing |
| Mar 31, 2025 | May 6, 2025 | $616.8M | $32.1M | $1.73 | Filing |
| Dec 31, 2024 | Feb 4, 2025 | $553.6M | $-216.2M | $-12.12 | Filing |
| Sep 30, 2024 | Oct 30, 2024 | $489.0M | $-36.8M | $-2.05 | Filing |
What would Allegiant Travel CO have to report for its valuation to change?
At $70.40, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 32.0% a year, to $6.02. On that path the next quarter needs diluted EPS near $-3.18, against $-2.41 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 32.0% | 32.0% |
| EPS needed in final year | $6.02 | $6.02 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. ALGT goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.